PAVmed (PAVM) Other financing activities (2018 - 2024)
PAVmed's (PAVM) quarterly Other financing activities came in at $353000.0 in Q1 2024, up 93.96% year-on-year from $182000.0 in Q2 2023, and up 358.44% quarter-over-quarter from $77000.0 in Q3 2023.
PAVmed (PAVM) Other financing activities (2018 - 2024) Analysis & Trends
PAVmed's Other financing activities history runs 6 years deep, the most recent figure standing at $353000.0 for Q1 2024.
- On a quarterly basis, Other financing activities rose 93.96% year-over-year to $353000.0 in Q1 2024; TTM through Dec 2024 was $77000.0, a 70.27% decrease from a year earlier, with the FY2024 full-year figure at $62000.0, down 76.06% from the prior year.
- Other financing activities grew to $353000.0 in Q1 2024 per PAVM's latest filing, from $77000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $61.0 million in Q4 2021 and bottomed at -$1.1 million in Q2 2021.
- The 5-year median for Other financing activities is $77000.0 (2023), against an average of $4.8 million.
- Biggest YoY gain for Other financing activities was 872200.0% in 2021; the steepest drop was 15414.29% in 2021.
- Year by year, Other financing activities stood at -$7000.0 in 2020, then soared by 872200.0% to $61.0 million in 2021, then tumbled by 99.91% to $55000.0 in 2022, then surged by 40.0% to $77000.0 in 2023, then jumped by 358.44% to $353000.0 in 2024.
- Per Business Quant, the three latest PAVM Other financing activities figures stand at $353000.0 (Q1 2024), $77000.0 (Q3 2023), and $182000.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 353,000.00 |
| Mar 31, 2024 | 353,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Sep 30, 2022 | 55,000.00 |
| Sep 30, 2022 | 55,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 241,000.00 |
| Mar 31, 2022 | 241,000.00 |
| Dec 31, 2021 | 61.05 Mn |
| Dec 31, 2021 | 61.05 Mn |
| Sep 30, 2021 | 649,000.00 |
| Sep 30, 2021 | 649,000.00 |
| Jun 30, 2021 | -1.07 Mn |
| Jun 30, 2021 | -1.07 Mn |
| Mar 31, 2021 | 1.38 Mn |
| Mar 31, 2021 | 1.38 Mn |